2019-04-10

Positive results for Buvidal® in treatment for fentanyl dependence

New positive results from a Phase 3 study show that Camurus’ Buvidal® provides better treatment effect for fentanyl abuse, among other things, compared to other standard treatments as well as lower withdrawal and drug craving.

New positive results from a Phase 3 study show that Camurus’ Buvidal® provides better treatment effect for fentanyl abuse, among other things, compared to other standard treatments as well as lower withdrawal and drug craving.

Read more at Camurus’ website: https://www.camurus.com/pressreleases/

Latest news

2022-10-03

Sandberg Development invests in the water innovation company Drupps

In alignment with the group’s investment philosophy, Sandberg Development has invested in the Swedish water innovati…

Read more

2022-08-16

Cooperation with Lund University, Faculty of Engineering

Sandberg Development will be the main sponsor of the reception of new students in the Embedded Electronics Engineeri…

Read more

2022-04-29

RESCUE Intellitech Launches DeconWasher™ Pro S at the 2022 FDIC International

On Thursday, April 28, it was finally time for RESCUE Intellitech to launch their new machine, the DeconWasher™ Pro…

Read more

2022-04-06

Camurus Annual Report for 2021

Camurus Annual Report for 2021 is now available at the company's website.

Read more

2022-04-05

Stefan Persson has joined Sandberg Development

On March 21, 2022, Stefan Persson joined the Sandberg Development Group as the new President and CEO. He takes over…

Read more